University of Wisconsin
School of Medicine and Public Health

University of Wisconsin Infectious Disease Research

The Infectious Disease division leads research across a broad spectrum of pathogens and disease states.


  • Drug Discovery and Development
  • Pharmacodynamics
  • Resistance Mechanisms
  • Stewardship



  • COVID-19
  • Microbiome
  • Nosocomial Infections
  • HIV
  • Transplant Infectious Diseases
  • Global Health and Emerging Infectious Diseases



  • Mycology
  • Virology
  • Infectious Disease Evolution


Members of the division compose just a fraction of the collaborative microbial sciences research on the UW campus that exists in numerous departments and colleges. The UW microbial sciences research program was ranked in the top two nationally by US World and News Reports in 2019.

Current research opportunities: COVID, antimicrobial drug resistance, antimicrobial stewardship, antimicrobial drug discovery, antimicrobial pharmacokinetics and pharmacodynamics, infection control and prevention, C difficile, fungal infections, transplant infectious diseases, HIV, HCV, infectious disease and social justice, global health, microbiome, virology, diabetic foot infections, biofilm infections, and immunology. 

ID Week 2020

ID WEEK 2020

Our Division at ID Week!

Posters and Abstracts

Kaitlyn E Molina BS, Brie N Noble, BS,  Christopher J Crnich, MD, PhD, Jessina C McGregor, PhD, FHSEA, David T Bearden, PharmD, FIDP, Dominic Chan, PharmD, BCPS, Jon P Furuno, PhD, FSHEA.  Frequency and Outcomes of Patients Prescribed Antibiotics for Extended Durations on Discharge from the Hospital to Nursing Homes.

Lindsay N Taylor, MD (fellow), Micahel Howe, MS (Grad Student), Christopher Crnich, MD, PhD.  Evaluating a Novel Antibiogram Format for use in Wisconsin Nursing Homes.

Hailey N Colangeli, BS, Brie N Noble, BS,  Christopher J Crnich, MD, PhD, Jessina C McGregor, PhD, FHSEA, David T Bearden, PharmD, FIDP, Dominic Chan, PharmD, BCPS, Jon P Furuno, PhD, FSHEA.  Frequency and Characteristics of Patients Switched from Intravenous to Oral Antibiotic Therapy on Discharge  to Nursing Homes.

Tyler L Lantz, BS, Brie N Noble, BS,  Christopher J Crnich, MD, PhD, Jessina C McGregor, PhD, FHSEA, Dominic Chan, PharmD, BCPS, Jon P Furuno, PhD, FSHEA, David T Bearden, PharmD, FIDP.  Healthcare utilization outcomes of patients prescribed fluoroquinolones on discharge from the hospital to nursing homes.

Chi-Yin Liao, MS, James Ford II, PhD, Christopher J Crnich, MD, PhD.  Antibiotic Prescribing Patterns for Residents in Assisted Living Facilities.

Darina G Georgieva, BS, Lucas T Schulz, PharmD, BCIDP, Fay Osman, MPH, Ambar Haleem, MD.  Risk Factors for Acute Kidney Injury after the Use of Antibiotic Loaded Bone Cement in Orthopedic Surgery – a Retrospective Case-control Study.

Grace A Schaack, Derrick Chen.  Comparison of the Abbott SARS – CoV-2 IgG and DiaSorin LIASON SARS – CoV-2 S1/S2 IgG Antibody Assays.

Grace A Schaack, Brittney Jung-Hynes, Derrick Chen. Nasal versus Nasopharyngeal Sample Collection for Diagnostic Nucleic Acid Amplification Testing for Influenza A, Influenza B, and Respiratory Syncytial Viruses.

Leigh R Berman, BA (medical student), Meredith Kavalier, MD (fellow), Besha Gelana, MSc, MPH, Daniel Yilma, MD, PhD, Getnet Tesfaw, MSc, Daniel Shirley, MD, MSc.  Assessment of Hand Hygiene amongst Health Care Professionals at Jimma University Medical Center.

Tola Ewers, MS, PhD, Babak Aryanfar, MD, Erin Balkenende, MPH, Marvin Bittner MD, MS, Suzanne F Bradely, MD, Madisen Brown, MS, Matthew Goetz, MD, Kalpana Gupta, MD, Christopher Hostler, MD, MPH, Eli Perencevich, MD, MS, Judith Strymish, MD, Gisel Urdaneta, MD, Christopher Crnich, MD, PhD.  Feasibility of Observing Traffic Patterns (FOOT Patter) in Veterans Health Administration Operating Rooms.

Dan F Smelter, Sue McCrone, Warren E Rose. Cefazolin inoculum effect predicts reduced susceptibility to other antibiotics and patient outcomes in MSSA endovascular infections.

BD Alexander, OA Cornely, PG Pappas, R Miller, M Johnson, J Vazquez, L Ostrosky-Zeichner, A Spec, R Rautemaa-Richardson, R Krause, GR Thompson, TJ Walsh, CG Morse, JW Sanders, D Andes, GM Lyon, FM Marty, MH Miceli, TF Patterson, M Hoenigl, N Azie, DA Angulo. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI).

Jamie Fergie, Manjiri Pawaskar, Phani Veeranki, Salome Samant, Carolyn Harley, Joanna MacEwan, Taylor Schwartz, Shikha Surati, James H Conway. Current Practices in the Diagnosis and Treatment of Varicella Infections in the United States.

Warren Rose, Benjamin Heikkinen, Janet Raddatz, Laura Puzniak, Ryan Dillion, Lucas Schulz.  Activity of anti-pseudomonial antibiotics among all Pseudomonas aeruginosa (PSA) at an academic medical health system, including beta-lactam, mutli-drug (MDR) and extensively drug resistant (XDR) strains.


David Andes

  • Candida Biofilms: What Makes Them so Bad?
  • New Kids on the Block: Antifungal Drug Pipeline

Jeniel Nett

  • Top 8 Papers in Medical Mycology
  • Top 8 Papers in Medical Mycology: Scientific Advances
  • Bad Bugs – Any Drugs

Oral Abstracts

Aurora Pop-Vicas (co-authors: Ambar Haleem, Fauzia Osman, Robert Striker, Nasia Safdar, Daniel Shirley)

  • Long Term Care Facility Residents Hospitalized with COVID-19 Infection Present with Atypical Systems